ZP
CELL

Zimmer Partners’s PhenomeX Inc. Common Stock CELL Stock Holding History

Zimmer Partners’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,000
Closed -$382K – 178
2020
Q3 		$382K Buy
+5,000
New +$318K 0.01% 111

Other funds holding CELL

SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Zimmer Partners's CELL Position: Q4 2020 in Review

Zimmer Partners sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2020, closing a stake of 5,000 shares — an estimated $382K sold.

Zimmer Partners first reported a position in CELL in Q3 2020 and held it in 1 quarter. The position peaked at $382K in Q3 2020. 113 funds tracked by Wall St. Rank hold CELL as of Q4 2020.

  • Zimmer Partners reported no remaining PhenomeX Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Zimmer Partners sold 5,000 PhenomeX Inc. Common Stock shares in Q4 2020, an estimated $382K.
  • Zimmer Partners first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Zimmer Partners's PhenomeX Inc. Common Stock position peaked at $382K in Q3 2020.
  • 113 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2020.

Based on Zimmer Partners's 13F filing for Q4 2020, filed 16 Feb 2021.